Z. Chen

发表

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza.

T. Iwasaki, T. Kurata, K. Matsuo, 1998, Vaccine.

Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin).

H. Tsujimoto, T. Iwasaki, T. Kurata, 2000, Vaccine.

Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry

D. Ho, Zhiwei Chen, P. Marx, 1997, Journal of virology.

Characterization of a pathogenic H9N2 influenza A virus isolated from central China in 2007

Z. Sui, Z. Chen, R. Wu, 2008, Archives of Virology.

Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.

R. Rowland, Z. Chen, P. Plagemann, 1994, The Journal of general virology.

Avian reovirus-induced syncytium formation is independent of infectious progeny virus production and enhances the rate, but is not essential, for virus-induced cytopathology and virus egress.

S. Walsh, R. Duncan, Z. Chen, 1996, Virology.

Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination.

H. Tsujimoto, T. Iwasaki, T. Kurata, 2000, Vaccine.

Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.

F. Fang, J. Wu, Z. Chen, 2010, Vaccine.

Identification of a murine CD4+ T-lymphocyte response site in hepatitis C virus core protein.

I. Berkower, H. Alter, Ziping Chen, 1996, Molecular immunology.

Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.

K. Komase, T. Iwasaki, T. Kurata, 2001, Vaccine.

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.

T. Kurata, S. Tamura, K. Matsuo, 1999, The Journal of general virology.

Genetic control of the murine humoral response to distinct epitopes of hepatitis C virus core protein

I. Berkower, H. Alter, W. Ching, 1995, Journal of viral hepatitis.

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.

Hidehiro Takahashi, T. Iwasaki, T. Kurata, 1999, Vaccine.

Sequence of the genome of lactate dehydrogenase-elevating virus: heterogenicity between strains P and C.

G. Palmer, K. Faaberg, Z. Chen, 1995, Virology.

Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals

Zhi Chen, Z. Chen, R. Dennin, 1999, Clinical chemistry and laboratory medicine.

High-frequency homologous genetic recombination of an arterivirus, lactate dehydrogenase-elevating virus, in mice and evolution of neuropathogenic variants.

Z. Chen, P. Plagemann, K. Li, 1999, Virology.

Novel Betapapillomavirus Associated With Hand and Foot Papillomas in a Cynomolgus Macaque

R. Burk, J. Cline, C. E. Wood, 2011, Veterinary pathology.

The Recombinant Nonstructural Polyprotein NS1 of Porcine Parvovirus (PPV) as Diagnostic Antigen in ELISA to Differentiate Infected from Vaccinated Pigs

Huanchun Chen, Y. Tan, Z. Chen, 2006, Veterinary Research Communications.

Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys

D. Ho, L. Zhang, A. Gettie, 1997, Journal of virology.

Sequences of 3' end of genome and of 5' end of open reading frame 1a of lactate dehydrogenase-elevating virus and common junction motifs between 5' leader and bodies of seven subgenomic mRNAs.

R. Rowland, K. Faaberg, Z. Chen, 1993, The Journal of general virology.

Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop

D. Ho, L. Zhang, A. Gettie, 1996, Journal of virology.

Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.

D. Ho, Zhiwei Chen, A. Gettie, 1998, Virology.

Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection

R. Rowland, G. Palmer, Z. Chen, 1997, Journal of virology.

Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell.

Z. Chen, P. Plagemann, Z. Chen, 1997, Journal of virological methods.

Chemokine Coreceptor Usage by Diverse Primary Isolates of Human Immunodeficiency Virus Type 1

J. Phair, D. Ho, Steven Wolinsky, 1998, Journal of Virology.

Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine.

K. Komase, T. Kurata, K. Matsuo, 1999, Vaccine.

Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.

J. Dou, M. Zhang, C. Xu, 1999, Chinese medical journal.

[Experimental study of immunization of mice with hepatitis C virus genetic vaccine constructs].

J. Dou, Z. Chen, K. Liu, 1999, Zhonghua nei ke za zhi.

Neuropathogenicity and susceptibility to immune response are interdependent properties of lactate dehydrogenase-elevating virus (LDV) and correlate with the number of N-linked polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein.

R. Rowland, Z. Chen, P. Plagemann, 1998, Advances in experimental medicine and biology.

Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.

R. Rowland, Z. Chen, P. Plagemann, 1999, Journal of neurovirology.

Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.

Z. Chen, P. Plagemann, K. Li, 2000, Virology.

The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein.

Z. Chen, P. Plagemann, K. Li, 1998, Virology.

Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution

Z. Chen, P. Plagemann, K. Li, 2001, Archives of Virology.

Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization.

G. Glass, J. Childs, Z. Chen, 2000, Virus research.

Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection.

R. Rowland, Z. Chen, P. Plagemann, 1998, Journal of neurovirology.

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

T. Kurata, S. Tamura, K. Matsuo, 2000, Vaccine.

Protection against influenza B virus infection by immunization with DNA vaccines.

T. Kurata, S. Tamura, T. Yoshikawa, 2001, Vaccine.

Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.

T. Iwasaki, T. Kurata, S. Tamura, 1998, The Journal of general virology.

Genetic and serotypic characterization of Sin Nombre-like viruses in Canadian Peromyscus maniculatus mice.

M. Drebot, H. Artsob, E. Mackow, 2001, Virus research.

The function of simian chemokine receptors in the replication of SIV.

P. Marx, Z. Chen, Zhiwei Chen, 1998, Seminars in immunology.